The presence of anti-zein IgA but not IgG antibodies in the CD, IBS, and even healthy control groups could be explained by the differential exposure and access of the zein antigen to the mucosal versus systemic immunological environment. This evidence concerns the gene CD79A and irritable bowel syndrome.